Search clinical trials for: de novo or partial responder to somatostatin analogues

Total 494142 results

Italfarmaco

Completed

Phase II Study With ITF2984 in Acromegalic Patients (POC)

Acromegaly

France, Hungary, Netherlands, Serbia, Czech Republic, Italy, Spain, Poland, Romania
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
University Hospital, Antwerp
Erasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research... and other collaborators

Recruiting

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients (SAUNA)

Gastroenteropancreatic Neuroendocrine Tumor

Netherlands, Belgium
University Hospital, Strasbourg, France

Recruiting

Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery (STOP-SST)

Acromegaly

France
Yanjing Gao
Shandong Provincial Hospital; Jinan Military General Hospital

Completed

The Treatment of Hepatocirrhosis and Portal Hypertension

Portal Hypertension | Hepatic Cirrhosis

China
Ipsen

Completed

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours (STREET)

Gastroenteropancreatic Neuroendocrine Tumours

Sweden
Mayo Clinic

Completed

Pasireotide LAR in Severe Polycystic Liver Disease (SOM230)

Autosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin Analogs

United States
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors (LUTHREE)

Neuroendocrine Tumors

Italy
European Organisation for Research and Treatment...
Ipsen

Withdrawn

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome (TELEFIRST)

Small Intestinal NET | Carcinoid Heart Disease
Novartis Pharmaceuticals

Completed

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Acromegaly

Italy, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
University Hospital, Grenoble

Completed

Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues (PHRC-Merkel)

Carcinoma, Merkel Cell

France
Federico II University
University of Genova; University Hospital, Udine, Italy; University of Perugia...

Completed

High Dose Somatostatin Analogues in Neuroendocrine Tumors (HIDONET)

Gastrointestinal Neoplasms | Respiratory Tract Neoplasms | Pancreatic Neoplasms | Multiple Endocrine Neoplasia | Thymic Neoplasms

Italy
Federico II University
Ospedali dei Colli

Completed

GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma (SS-HCC)

Advanced Hepatocellular Carcinoma

Italy
Instituto do Cancer do Estado de São Paulo

Not yet recruiting

Study to Compare Two Partial Nephrectomy Techniques for Renal Tumors: Robot-assisted vs Videolaparoscopic (VPN x RANP)

Renal Cancer
ITM Solucin GmbH

Not yet recruiting

Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors (KinLET)

Lymphoma | CNS Tumor | Solid Tumor, Childhood | Somatostatin Receptor Positive | NET
National Cancer Institute (NCI)

Not yet recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Pheochromocytoma | Somatostatin Receptor Positive | Paragangliomas | Gastrointestinal Neuroendocrine Tumors

United States
Menoufia University

Recruiting

Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.

Renal Cell Carcinoma

Egypt
MedSIR
Stemline Therapeutics, Inc.

Not yet recruiting

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. (ADELA)

Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
EDAP TMS S.A.

Recruiting

ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer (ES-HIFU)

Prostate Cancer

Spain
Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
The Netherlands Cancer Institute

Recruiting

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (PAPBI-3)

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Merck Sharp & Dohme LLC

Not yet recruiting

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer (PRIAM)

Urologic Neoplasms | Urogenital Neoplasms | Penile Cancer | Male Urogenital Diseases | Penile Squamous Cell Carcinoma | Locally Advanced Penile Carcinoma
Al-Azhar University

Recruiting

Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy

Renal Tumor | Renal Malignant Tumor

Egypt
Azienda Ospedaliera Universitaria Integrata Verona

Recruiting

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K) (COMPAR-K)

Renal Carcinoma

Italy
Case Comprehensive Cancer Center

Not yet recruiting

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Muscle Invasive Bladder Carcinoma | Malignant Neoplasm of Bladder

United States
American University of Beirut Medical Center

Not yet recruiting

Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry

Anesthesia, General | Respiratory Distress Syndrome | Oxygen Saturation
Karolinska University Hospital

Recruiting

Resection or Ablation of Small Kidney Tumors (RESTART)

Kidney Cancer

Sweden
Nanjing Children's Hospital

Recruiting

A Prospective Study on the Treatment of cLM Based on ICG Imaging

Lymphatic Malformation

China
Regeneron Pharmaceuticals

Recruiting

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)

B-Cell Non-Hodgkin Lymphoma (B-NHL)

Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Ruijin Hospital

Recruiting

A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries (SPiM-RWS-URO)

Urological Surgeries

China
University of Washington
Breast Cancer Research Foundation

Not yet recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...

United States
Providence Health & Services

Recruiting

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Primary Central Nervous System Lymphoma

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis

Autoimmune Encephalitis | Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis

China
IRCCS San Raffaele

Recruiting

Kidney Cancer Observational Protocol

Renal Cancer

Italy
Erasmus Medical Center

Recruiting

Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response (NIVOPTIMIZE)

Melanoma

Netherlands
Pfizer

Recruiting

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Advanced or Metastatic Breast Cancer

United States, Taiwan, Japan, China, Canada, Korea, Republic of, Israel, Argentina, Australia, Brazil, Mexico, United Kingdom
Instituto do Cancer do Estado de São Paulo

Recruiting

Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.

Esophageal Neoplasms | Dysphagia

Brazil
University of Leipzig

Recruiting

Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy (3DPN)

Kidney Tumor

Germany
Istanbul University - Cerrahpasa (IUC)

Not yet recruiting

A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score

Unconsciousness | Traumatic Brain Injury | Subarachnoid Hemorrhage | Coma | Infratentorial Neoplasms | Epilepsy, Temporal Lobe | Assessment, Self | Intensive Care Neurological Disorder | Arnold Chiari Malformation | Cerebrovascular Event | Postoperative Intracranial Hematoma | Postoperative Intracranial Haemorrhage and other conditions

Turkey
Guangdong Provincial People's Hospital

Recruiting

Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy (SPPDPL)

Laryngeal Cancer | Dysphagia

China
Integro Theranostics

Recruiting

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Breast Cancer | DCIS | Invasive Duct Carcinoma of Breast

United States
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone (TCRM)

Submucous Leiomyoma of Uterus

China
Peking University

Not yet recruiting

Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

China
Tianjin Medical University Cancer Institute and...

Recruiting

A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

HR Positive HER2 Negative Advanced Breast Cancer

China
Centre of Postgraduate Medical Education

Recruiting

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Renal Cell Carcinoma | Kidney Neoplasm

Poland
University of Miami

Recruiting

NSAID Use After Robotic Partial Nephrectomy (No-PAIN)

Kidney Cancer | Renal Cancer | Renal Neoplasm

United States
Fondazione del Piemonte per l'Oncologia

Recruiting

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer (RETURN)

Prostate Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation (PBReI)

Breast Cancer | Recurrent

Italy

Search clinical trials for: de novo or partial responder to somatostatin analogues

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations